Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€55.16

€55.16

-8.530%
-5.54
-8.530%
€60.00

€60.00

 
06.05.21 / Tradegate WKN: A2AG6H / Symbol: NTLA / Name: Intellia / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€60.00
04.01.21
buy
-
04.09.20
€30.00
21.05.20
buy
€44.00
21.10.19
buy
€22.55
11.03.19
buy
Your prediction

Intellia Therapeutics Inc Stock

Heavy losses for Intellia Therapeutics Inc today as the stock fell by -€5.540 (-8.530%).
Currently there is a rather positive sentiment for Intellia Therapeutics Inc with 4 Buy predictions and 1 Sell predictions.
With a target price of €60.00 there is a slightly positive potential of 8.774% for Intellia Therapeutics Inc compared to the current price of €55.16.
So far the community has only identified positive things for Intellia Therapeutics Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Intellia Therapeutics Inc in the next few years

Pros
2
Could be worthwhile Investment >10% per year
Cons
0
-

Performance of Intellia Therapeutics Inc vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Intellia Therapeutics Inc -8.530% -16.500% -17.696% 330.097% 22.551% 214.302% -
Chromadex Corp -0.690% 1.389% -12.048% - - - -
Organovo Holdings Inc. -5.810% -17.735% -27.871% -32.520% -44.679% -69.698% -86.987%
Matinas BioPharma Holdings Inc -1.440% -8.219% -24.294% - -27.568% - -

Other discussions about Intellia Therapeutics Inc Stock

New thread Forum